New GNN Predicts Protein-Ligand Binding Affinity with Curvature Information
Key takeaways
- CPES is a new graph neural network for improved protein-ligand binding affinity prediction.
- It incorporates physics-informed curvature representations to model molecular flexibility and binding-induced changes.
- The model uses spectral cross-attention to capture dynamic conformational changes.
- CPES offers enhanced predictive performance and physical interpretability, crucial for drug discovery.
Who benefits
Summary
Researchers propose CPES, a curvature-informed potential energy surface graph neural network for predicting protein-ligand binding affinity. It incorporates physics-informed curvature representations to model molecular flexibility and binding-induced conformational changes, improving accuracy over methods relying solely on static interaction geometry.
Why it matters
This advancement significantly improves the accuracy of predicting how well drugs bind to proteins, which is fundamental for accelerating drug discovery and development. Professionals in pharmaceutical research and computational chemistry can design more effective and targeted drug candidates with greater efficiency.
How to implement this in your domain
- 1Explore CPES or similar curvature-informed graph neural networks for protein-ligand binding affinity prediction in drug discovery pipelines.
- 2Integrate physics-informed curvature representations to account for molecular flexibility and conformational changes during binding.
- 3Utilize spectral cross-attention mechanisms to compare unbound and bound molecular states and capture dynamic interactions.
- 4Apply this method to screen potential drug candidates, optimize lead compounds, and predict off-target effects more accurately.
- 5Collaborate with computational chemists to validate and refine the model's predictions against experimental data.
Original post by Peng-Fei Sun, Chuan-Xian Ren, Hong Yan
"arXiv:2606.14217v1 Announce Type: new Abstract: Accurate prediction of protein-ligand binding affinity is essential for structure-based drug discovery. Recent geometric deep learning methods have achieved promising performance by representing protein-ligand complexes as three-dim…"
View on XOriginally posted by Peng-Fei Sun, Chuan-Xian Ren, Hong Yan on X · view source
Want to go deeper?
Turn these trends into skills with Learnijoy's hands-on AI & tech courses.
Explore coursesMore in AI Research
LFM2.5-VL-3B Enhances Edge Vision Capabilities
A new model, LFM2.5-VL-3B, is introduced to provide better and faster vision capabilities specifically optimized for edge devices. This advancement aims to improve performance and efficiency for AI applications running locally.
Tiered KV Cache Boosts Large LLM Inference on SageMaker HyperPod
Running large language model inference at scale often involves a trade-off between large GPU instances and slow time-to-first-token due to KV cache limitations. This post describes building a tiered KV cache on Amazon SageMaker HyperPod, extending the cache into a shared, distributed NVMe pool with Curvine, allowing replicas to reuse cache at near-local-disk speeds on cost-efficient instances.
AI-Generated Dog Cancer Vaccine Idea Leads to New Startup
An Australian entrepreneur, Paul Conyngham, has launched Gamgee, a startup focused on personalized mRNA cancer vaccines for dogs, inspired by an AI-generated concept for his own pet. The company aims to expand its AI and genetics-driven personalized treatments to other species, including humans.